It is well-established that subcompartments of endoplasmic reticulum (ER) are in physical contact with the mitochondria. These lipid raft-like regions of ER are referred to as mitochondria-associated ER membranes (MAMs), and they play an important role in, for example, lipid synthesis, calcium homeostasis, and apoptotic signaling. Perturbation of MAM function has previously been suggested in Alzheimer's disease (AD) as shown in fibroblasts from AD patients and a neuroblastoma cell line containing familial presenilin-2 AD mutation. The effect of AD pathogenesis on the ER-mitochondria interplay in the brain has so far remained unknown. Here, we studied ERmitochondria contacts in human AD brain and related AD mouse and neuronal cell models. We found uniform distribution of MAM in neurons. Phosphofurin acidic cluster sorting protein-2 and σ1 receptor, two MAM-associated proteins, were shown to be essential for neuronal survival, because siRNA knockdown resulted in degeneration. Up-regulated MAM-associated proteins were found in the AD brain and amyloid precursor protein (APP) Swe/Lon mouse model, in which up-regulation was observed before the appearance of plaques. By studying an ER-mitochondria bridging complex, inositol-1,4,5-triphosphate receptor-voltage-dependent anion channel, we revealed that nanomolar concentrations of amyloid β-peptide increased inositol-1,4,5-triphosphate receptor and voltage-dependent anion channel protein expression and elevated the number of ER-mitochondria contact points and mitochondrial calcium concentrations. Our data suggest an important role of ER-mitochondria contacts and cross-talk in AD pathology.
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AD mouse models | hippocampal neurons | human cortical brain tissue E vidence for impaired mitochondrial function has been shown in Alzheimer's disease (AD) patients as well as animal and cell models of AD (1) . In addition to their crucial role in energy production through oxidative phosphorylation, mitochondria have central roles in apoptotic signaling, lipid synthesis, and intracellular calcium (Ca 2+ ) buffering. The outer mitochondrial membrane is in contact with a subregion of endoplasmic reticulum (ER) referred to as mitochondria-associated ER membranes (MAMs). MAMs are intracellular lipid rafts that regulate Ca 2+ homeostasis, metabolism of glucose, phospholipids, and cholesterol (2) (3) (4) (5) (6) . Strikingly, all of these processes are altered in AD (7) . The interplay between these two organelles has been studied extensively, and several MAM-associated proteins have been characterized (6, 8) . Such proteins include multiple lipid synthesizing enzymes [e.g., phosphatidylserine synthase-1 (PSS1), fatty acid CoA ligase 4 (FACL4) (4, 5, 9) , and proteins involved in Ca 2+ signaling]. Ca 2+ is essential for the bioenergetics of the mitochondria and transferred from the ER at MAM (3) by inositol-1,4,5-triphosphate receptors (IP3Rs; ER side) and voltage-dependent anion channel (VDAC1; mitochondria side) to form bridging complexes (e.g., IP3R1-VDAC1) (10, 11) . Another protein suggested to be involved in Ca 2+ regulation at MAM is the σ1 receptor (σ1R). σ1R is a molecular chaperone located in the ER-mitochondria interface on both the ER side, where it is involved in calcium homeostasis by stabilizing IP3R type 3 (IP3R3) (12) , and the mitochondrial side (13) , where its function is less established. Additionally, phosphofurin acidic cluster sorting protein-2 (PACS-2) and mitochondrial dynamin-related fusion protein (Mfn2) have been described to be located at the ER-mitochondria interface. PACS-2 is a multifunctional vesicular sorting protein that controls membrane traffic, apoptosis, and ER-mitochondria tethering (14) . Mfn2 has also been described to be involved in tethering (15) and regulation of mitochondrial dynamics.
One neuropathological hallmark in AD is accumulation of amyloid β-peptide (Aβ) in the brain. Aβ has been detected in mitochondria (16, 17) , and we have previously shown that Aβ is imported into the mitochondria through the Tom40 protein pore (18) . Recently, an increased ER-mitochondria connectivity was detected in human fibroblasts from individuals with familial AD (FAD) mutations in presenilin 1 (PS1), presenilin 2 (PS2), or amyloid precursor protein (APP) as well as fibroblasts from individuals with sporadic AD (2) . In agreement, similar results were obtained in neuroblastoma cells expressing PS2 FAD mutation (19) . The increased connectivity was further manifested by up-regulated MAM function, which was shown by enhanced phospholipid and cholesterol metabolism (2) and calcium shuttling (19) . If MAM in the brain responds in a similar way has not been investigated previously.
We identified MAM structures uniformly distributed in neurons as well as synapses. We observed a distinct increase in the expression of MAM-associated proteins in postmortem AD brain and APP Swe/Lon mice as well as elevated contact points between ER and mitochondria in primary hippocampal neurons after Aβ exposure. The increased contact points between the two organelles after Aβ exposure caused augmented ER-to-mitochondria Ca 2+ transfer in neuroblastoma cells. 1A) , cultured mouse hippocampal neurons (Fig. 1B) , and synaptosomal preparations (Fig. 1C) . ER protrusions covering ∼10% of mitochondrial surface were the most frequent MAM structure observed. PSS1, PACS-2, IP3Rs, σ1R, Mfn2, and VDAC1 are all proteins previously shown to be localized to the ER-mitochondria interface in a variety of organs (8) . Here, Western blot analysis also revealed expression of MAM-associated proteins in mouse brain. PSS1, PACS-2, and IP3Rs resided on the ER side, whereas σ1R, Mfn2, and VDAC1 proteins were mainly located in mitochondria ( Fig. 2A ). In the MAM fraction, we detected a higher expression of IP3R3 compared with IP3R1 ( Fig. 2A) . These results are consistent with findings showing that IP3R3 strongly colocalizes with mitochondria (25) and has the most profound effects on mitochondrial Ca 2+ concentration. Ca 2+ signaling through IP3R3 has been shown to be regulated by σ1R (12, 26) . We detected σ1R in fractions of both MAM and mitochondria ( Fig. 2A) . This finding is in agreement with the work by Klouz et al. (13) , which also found σ1R in the mitochondria. Immunocytochemical (ICC) staining and confocal microscopy showed that PSS1, PACS-2, IP3R3, σ1R, and VDAC1 are uniformly distributed in hippocampal neurons in both neurites (Fig. 2B ) and soma (Fig. S1 ). IP3R3 showed substantial overlap with VDAC1, indicating that ER and mitochondrial membranes are in close proximity (Fig. 2C, Upper) . In addition to ICC staining, the proximity ligation assay (PLA) was used. It verified that IP3R3 is indeed in close proximity (<40 nm) with VDAC1, which was previously shown for IP3R1 (10) (Fig. 2C,  Lower) . Thus, the previously described MAM-associated proteins PSS1, PACS-2, IP3R3, σ1R, Mfn2, and VDAC1 are also located in the ER-mitochondria interface in the brain, and IP3R3-VDAC1 is part of an ER-mitochondrial bridging complex.
Results

ER-Mitochondria
σ1R and PACS-2 Knockdown Causes Degeneration of Hippocampal
Neurons. Previous research shows that knockdown of PACS-2 in A7 melanoma cells causes loss of MAM-mitochondria coupling and Ca 2+ signaling (14) . Knockdown of σ1R in Chinese hamster ovary (CHO) cells causes decreased survival (12) . Here, the importance of proper ER-mitochondria interaction in neurons and glia was investigated using siRNA knockdown of PACS-2 or σ1R in mouse primary hippocampal cultures containing neurons and astrocytes ( Fig. 3 and Fig. S2C ). Cells were transfected with control siRNA, σ1R siRNA, or PACS-2 siRNA together with GFP using a Magnetofector system. Transfected hippocampal neurons expressing GFP were analyzed using confocal microscopy. Hippocampal neurons transfected with control siRNA showed long robust projections, whereas neurons transfected with either σ1R or PACS-2 siRNA degenerated 16 h after treatment (Fig. 3 ). Caspase-3 activity was detected in neurons transfected with either σ1R or PACS-2 siRNA, indicating activation of apoptosis (Fig. S2A ). The knockdown efficiency was confirmed by Western blot analysis in blastocyst-derived (BD8) cells treated with the same siRNAs (Fig. S2B ). BD8 cells were used, because the transfection efficiency of the hippocampal neurons was too low to be suitable for Western blot analysis. Similarly, astrocytes, stained with GFAP (marker for astrocytes), were progressively degenerating after transfection (Fig. S2C) . Thus, knockdown of PACS-2 and σ1R independently caused degeneration of hippocampal neurons and astrocytes, showing the importance of proper function of these MAM-associated proteins.
Altered Expression of PSS1, PACS-2, and σ1R in Human AD Brain and the APP Swe/Lon Mouse Model. Next, we investigated the expression of PSS1, PACS-2, and σ1R proteins. Overview pictures taken of mouse brain sections revealed widespread distribution of MAMassociated proteins in WT mice, which is shown here by PSS1 staining (Fig. S3A ). Higher magnification of the CA1 region of hippocampus clearly showed neuronal localization for PSS1, PACS-2, and σ1R in WT mice (Fig. S3B) . Next, we investigated the expression levels of PSS1, PACS-2, and σ1R at different disease stages. For this purpose, we used APP Swe/Lon and APP Arc mouse models as well as human postmortem cortical brain tissue. The APP Swe/Lon mouse model overexpresses the Swedish (K670N/ M671L) and London (V717I) mutations and progressively accumulates a large quantity of amyloid plaques (27) . Meanwhile, the APP Arc mouse model containing an intra-Aβ mutation at E693G has a less aggressive pathology with mainly diffuse Aβ deposits (28). Disease progression was followed in the APP Swe/Lon mouse model, in which Western blot analysis was performed at different time points (i) before Aβ deposition (2 mo of age), (ii) at mild Aβ pathology (6 mo of age), and (iii) at severe Aβ pathology (10 mo of age). In the APP Arc mouse model, the expression of PSS1, PACS-2, and σ1R proteins was analyzed only at a late disease stage (12 mo of age).
In the APP Swe/Lon mouse, the expression levels were analyzed in hippocampus, cortex, and cerebellum (Fig. 4A) . Statistical analysis revealed that PACS-2 levels were higher in all brain regions from APP Swe/Lon mice compared with WT mice (Fig. 4B) . The PACS-2 levels were increased in hippocampus already from 2 mo of age, whereas the increase started at 6 mo in cortex and cerebellum. A similar pattern was detected for σ1R, which also started to increase significantly in hippocampus at 2 mo of age. In contrast, PSS1 levels were only significantly increased in cerebellum (Fig. 4B) . Importantly, for PACS-2 and σ1R, the alterations in protein expression occurred already before plaque formation.
Opposite of the APP Swe/Lon mice, no significant differences in MAM protein expression were detected in hippocampus, cortex, or cerebellum isolated from APP Arc mice at the age of 12 mo (Fig. S3 C and D) . The discrepancy between these two mouse models might be explained by the different properties of the Aβ peptides formed, Aβ (in APP Swe/Lon ) and Aβ Arc (in APP Arc ). The Arctic mutation is situated inside Aβ at position E693G and enhances protofibril formation (29) without affecting fibrillization rate. The APP Arc mice display subtle cognitive decline, whereas the APP Swe/Lon mice show a more aggressive disease progression. Also, the localization of the neuropathological alterations is different between the two models: in the APP Arc mice, the lesions are mainly detected in the subiculum, which is in contrast to APP Swe/Lon mice, where Aβ deposits are spread throughout the neocortex (30) .
The analysis of MAM-associated proteins in human postmortem cortical tissue (three controls and three AD cases) revealed increased PSS1 and PACS-2 levels and decreased σ1R expression levels in the AD cases compared with control cases (Fig. 4 C and D) .
PSS1, PACS-2, FACL4, and σ1R mRNA Levels Are Stable in the APP Swe/Lon Mouse Model. For comprehensive analysis, we also included an in situ hybridization assay of mRNAs in the APP Swe/Lon mouse model. The quantification revealed similar levels and distribution patterns of PACS-2, PSS1, σ1R, and FACL4 mRNA (Fig. S4 ) in visual cortex, frontal cortex, and hippocampus at 2, 6, and 10 mo of age. A significant increase in PSS1 mRNA was detected in frontal cortex at 6 mo of age in the APP Swe/Lon mouse model compared with WT. However, the overall steady mRNA expression pattern observed comparing APP Swe/Lon with WT mice implicates that the augmented protein expression, detected by Western blot analysis, is most likely caused by protein stabilization, increased translation of already existing mRNA, and/or decreased protein degradation.
Phospholipid Metabolism Is Still Intact in Human AD Brain and the APP Swe/Lon Mouse Model. MAM is central in lipid synthesis, especially phospholipid synthesis. Phosphatidylserine (PtdSer) is transported at MAM from ER into mitochondria, where it is converted by phosphatidylserine decarboxylase into phosphatidylethanolamine (PtdEtn), which in turn, is transported back to ER for conversion into phosphatidylcholine, a major component of biological membranes. Recently, a more rapid conversion of PtdSer to PtdEtn was found in PS1-KO, PS2-KO, and double KO mouse embryonic fibroblast cell lines and fibroblasts from FAD and sporadic AD patients (2) . On the contrary, in AD brain, reduced levels of PtdEtn have been detected (31) . Here, we studied lipid levels in the APP Swe/Lon mouse model and human AD cortical tissue. Lipids were extracted from human AD and control cortical brain mitochondria as well as APP Swe/Lon Fig. 3 . MAM-associated protein depletion causes degeneration of hippocampal neurons. Hippocampal neurons were transfected with AllStar negative control siRNA or siRNA to PACS-2 or σ1R (30 nM) together with pEGFP-N1 vector (0.4 ng/μL). Live cell images taken 16 h after transfection. Fig. 4 . MAM-associated protein expression is altered in AD and AD mouse model. Western blot quantification of expression of MAM-associated proteins in (A and B) the APP Swe/Lon mouse brain (2, 6, and 10 mo old) and (C and D) the human cortical postmortem brain tissue. Data were compared using MannWhitney u test (APP Swe/Lon : mean ± SD, n = 4; human cortical brain tissue: mean ± SEM, n = 3; *P < 0.05). Data were normalized to (B) tubulin or (D) actin. mice brain mitochondria of 2-, 6-, and 10-mo-old animals. The levels of phosphatidylcholine, PtdSer, and cardiolipin were analyzed by thin liquid chromatography, and the results revealed no differences in lipid composition in the human or mouse material (Fig. S5) . With this method, no changes in lipid metabolism could be detected, which might suggest intact lipid metabolism in AD cortical brain tissue and the APP Swe/Lon mouse model.
Aβ Increases Contact Points Between ER and Mitochondria in Primary
Hippocampal Neurons. Cellular stress (e.g., ER stress) has been shown to modulate the interaction between ER and mitochondria. Bravo et al. (32) showed that ER stress induced by tunicamycin caused increased ER-mitochondrial coupling, Ca 2+ transfer, and mitochondrial metabolism. To investigate the effect of Aβ exposure on ER-mitochondrial contact points, we exposed primary hippocampal neurons to conditioned medium (CM) from CHO7PA2 cells expressing the FAD mutation, APPV717F (Indiana mutation). CHO7PA2 CM (16 h) contains naturally occurring oligomeric Aβ species and no fibrils (33). CHO7PA2 cells express high levels of APPV717F (Fig. 5A) , and the CM generated after incubation with 8 (CM) or 4 mL (CM*) neurobasal medium for 16 h contained ∼2.5 or 4.5 nM total Aβ (Aβ 40 + Aβ 42 ), respectively (Fig. 5B) . These concentrations are thought to resemble physiological conditions (34) . Hippocampal neuronal cultures were subsequently exposed to CM and CM* for 8 or 48 h. As a control, immunodepleted CHO7PA2 medium was used.
The effect of Aβ on ER-mitochondria contact points was analyzed in primary hippocampal neurons stained with IP3R3 (MAM) and VDAC1 (mitochondria) antibodies (Fig. 5C ). To investigate fluorescence intensity, we used the same instrumental setting for acquiring all pictures. Aβ treatment induced an increase in both IP3R3 (green) and VDAC1 (red) immunofluorescence (Fig. 5 C and D) along with increased colocalization (yellow) (Fig. 5C ). The increase in ER-mitochondria contact points was verified using PLA technology. Because the distance between ER and mitochondria is ∼20-40 nm (6) and PLA detects proteins located <40 nm away from each other, we used the IP3R3-VDAC1 pair to study the number of contact points after exposure to Aβ. A significant increase in PLA signal was observed after Aβ treatment (Fig. 5E ).
In conclusion, the data suggest that the expressions of VDAC1 and IP3R3 proteins increase after Aβ treatment and that the newly synthesized proteins take part in new contact points formed between ER and mitochondria. Thus, ER-mitochondria protein augmentation is not only observed at pathological conditions as detected in AD brain or in the APP Swe/Lon mouse model but also, after exposure to nanomolar concentrations of oligomeric Aβ.
Aβ and σ1R Agonist Treatment Increases Ca
2+ Transfer from ER to Mitochondria. ER stress has previously been shown to influence the ER-mitochondria coupling and their Ca 2+ cross-talk (32) . To detect changes in Ca 2+ shuttling after ER stress, the experiments were performed at an early time point (4 h), because prolonged stress abolished the effect (32) . Ca 2+ release from ER through IP3R3 has been previously shown to be regulated by σ1R (12) . Therefore, experiments were conducted in the presence or absence of a σ1R agonist (SA4503 Cutamesine, 1 μM). To study the influence of Aβ on the Ca 2+ machinery on both ER and mitochondrial sides, we used two experimental settings: one in which Ca 2+ shuttling from ER to mitochondria after bradykinin stimulation (100 nM) was measured and one where the mitochondrial Ca 2+ uptake machinery was separated from ER-Ca 2+ release in plasma membrane-permeabilized cells. SH-SY5Y cells expressing cytosolic or mitochondrial aequorins were exposed to SA4503 alone for 24 h to study if this treatment per se influenced cytosolic or mitochondrial Ca 2+ handling. The results revealed that neither cytosolic nor mitochondrial Ca 2+ response to bradykinin stimulation was affected (Fig. 6A) . Cell incubation for 4 h with CM* (Aβ, 4.5 nM) or tunicamycin (TUN; 1 μg/mL) in absence or presence of SA4503 showed no effect on cytosolic Ca 2+ responses ( Fig. 6 B and C) . However, mitochondrial Ca 2+ uptake was significantly increased after cotreatment with Aβ and SA4503 (Fig. 6 B and D) . Similar results were obtained from TUN ± SA4503 cotreatment (Fig. 6 E and F) . A possible explanation for such an effect would be that Aβ increases the intrinsic capacity of mitochondria to take up Ca 2+ . We explored this possibility by using the second experimental approach measuring mitochondrial Ca 2+ uptake in digitonin-permeabilized cells bathed with an intracellular-like buffer set at different Ca 2+ levels (micromolar). Under these conditions, the mitochondrial Ca 2+ peaks were significantly increased at all Ca 2+ concentrations tested by the Aβ treatment, suggesting a direct effect of the peptide on the molecular machinery responsible for mitochondrial Ca 2+ uptake (Fig. 6G) . Interestingly, when cells were treated with Aβ combined with the σ1R agonist, the increased mitochondrial Ca 2+ uptake in permeabilized cells induced by Aβ alone was abolished (Fig. 6G) . Thus, Aβ promotes Ca 2+ uptake mechanisms on the mitochondrial side, whereas SA4503 combined with Aβ has dual effects both promoting ER Ca 2+ release and inhibiting mitochondrial Ca 2+ uptake.
Discussion
The close contact points between ER and mitochondria at specialized regions of ER (i.e., MAMs) are important for, for example, lipid synthesis and Ca 2+ handling and have previously been described in several cell models (3) . In neurons, the interaction between ER and mitochondria in synapses has been postulated to shape intracellular Ca 2+ signals and modulate synaptic and integrative neuronal activities (22) . Here, we report that the neuronal MAM structure is uniformly distributed throughout hippocampal neurons, and it also exists in synapses and appears as short ER stretches connected to the mitochondrial surface. MAM seems to harbor physiological functions with particular importance for neuronal integrity, because knockdown of PACS-2 or σ1R resulted in degeneration. The atrophy started distally and advanced to the cell body, which is a fashion resembling dying-back neuropathy (35) . Also, astrocytes responded in a similar manner, which was not unexpected; the astrocytes most likely are heavily dependent on a functional MAM for, for example, cholesterol metabolism, because the astrocytes are the net producers of cholesterol in the brain (36) .
Up-regulated function of MAM and increased ER-mitochondrial interaction have recently been observed in human fibroblasts from familial and sporadic AD patients (2) . Here, data gathered from neuronal cells exposed to Aβ and human AD cortical tissue as well an AD mouse model robustly revealed that this region, indeed, is affected by AD pathogenesis. We could detect an upregulation of MAM-associated proteins in the APP Swe/Lon mouse model at 2, 6, and 10 mo of age. Hence, alterations occur already at 2 mo of age before plaques are visible. Also, in the human AD cortical tissue, up-regulation was detected; however, one of the MAM-associated proteins, σ1R, was significantly decreased. In concordance, decreased levels of σ1R have been detected postmortem in the hippocampus (37) and in living patients already at an early AD disease stage using imaging techniques (38) . The discrepancy in σ1R expression between the mouse model and the human tissue might be explained by pathology dissimilarities, because the mouse model lacks several human pathogenic hallmarks. In an early stage of AD, the increased expression of ER-mitochondria interface proteins may reflect a stress response, where neurons try to maintain proper functions in this crucial region.
The data from the AD mouse model APP Arc raised yet another dimension to the complexity of the mechanism involved in MAM region regulation, because no alteration in MAM was detected. The divergence of impact on MAM observed in the APP Swe/Lon vs. APP Arc mouse models might be explained by the milder pathology in the APP Arc mouse model. APP Arc has an intra-Aβ mutation causing predominately diffuse Aβ deposits in restricted areas (28, 29) . It is interesting that an intra-Aβ mutation vs. mutations at β-and γ-cleavage sites generate such diverse MAM phenotypes. These findings suggest that certain Aβ properties are necessary for regulation of MAM and need additional investigation.
Aβ exposure of primary hippocampal neurons affected the MAM region by increasing both the MAM-associated protein expression and the number of contact points between ER and mitochondria, here revealed by studying the IP3R3-VDAC1 bridging complex. Moreover, we found Ca 2+ regulatory mechanisms on the mitochondrial side to particularly be affected by Aβ. We investigated these mechanisms by using two different experimental settings: one studying the transfer of Ca 2+ from ER to the mitochondria (intact cells) and one studying mitochondrial Ca 2+ uptake independent of ER-Ca 2+ release (plasma membranepermeabilized cells). Accordingly, Aβ has been shown to bind and affect several proteins in the inner mitochondrial membrane of the mitochondria (e.g., cyclophilin D and COX) (39, 40) . Calcium release from ER through IP3R3 has previously been shown to be regulated by σ1R (12) . Our data suggest that the σ1R agonist (SA4503) could regulate the Ca 2+ machinery on both sides during stress (induced by Aβ or TUN) in opposite ways. The dual effect of SA4503 treatment might be explained by the subcellular localization of σ1R to both mitochondria and MAM, implying different functions of σ1R when located on the mitochondrial vs. ER side. Our results indicate diverse functions of σ1R at the mitochondria-ER interface which need additional investigation. As a source for Aβ, we used the well-characterized CHO7PA2-CM containing nanomolar concentrations of naturally occurring oligomeric Aβ (33) that resembles the physiological concentrations to which neurons are exposed in the brain (34) . It should be emphasized that, in our model system, we applied Aβ on the outside of the cells. Thus, Aβ could initiate signal transduction pathways and/or be internalized and trafficked inside the neurons. It may be speculated that Aβ is taken up by cells through endocytosis and reaches the ER-mitochondria region by transport in endosomes. Soluble Aβ in CHO7PA2-CM has previously been shown to inhibit long-term potentiation in hippocampal slices (41) . Here, we show the direct or indirect influence on MAM, suggesting yet another physiological function of Aβ. Data were compared using ANOVA followed by Games/Howell posthoc test (mean ± SD, n = 4; *P < 0.05). (E) For quantification of VDAC1 and IP3R3 interaction, we performed PLA on 8-h CM*-treated hippocampal neurons. The fluorescent spots (PLA signals) obtained using Duolink detection fluorophore Far-red ex644 were analyzed using Duolink Imaging Tool software. Data were compared using Mann-Whitney u test (mean ± SD, n = 3; *P < 0.05). In conclusion, we show that nanomolar concentrations of oligomeric Aβ regulate ER-mitochondrial communication and mitochondrial Ca 2+ . The findings of augmentation of MAM-associated proteins in AD brain, APP Swe/Lon mice, and primary neurons exposed to Aβ indicate that this region is implicated in AD pathogenesis and might harbor potential targets for new treatment strategies.
Materials and Methods
Additional details are given in SI Materials and Methods.
Cell Culture and Transfection. Primary hippocampal neurons (embryonic days [16] [17] were cultured in Neurobasal medium + B27 supplement in the presence of a surrounding feeder layer of cortical neurons (42, 43) . BD8 cells were grown according the work in ref. 44 . Cells were transfected using magnetic-assisted transfection. GFP and siRNA were mixed in Opti-MEM and NeuroMag according to the manufacturer's instructions (OZ Biosciences).
Brain Tissue. APP Swe/Lon and APP Arc mouse models were generated as described in refs. 45 and 28, respectively. Human brain tissue was provided by the Brain Bank at Karolinska Institutet. Subcellular Fractionation and MAM Purification. To isolate MAM, mouse brains from adult C57B6/J mice were rapidly taken and prepared as previously described (46) . Synaptosomes were isolated according to ref. 47 .
PLA. The interaction between IP3R3 and VDAC1 was analyzed in hippocampal neurons by PLA technology performed according to the manufacturer's instructions (Olink Bioscience).
Aequorin Ca 2+ Measurements. Aequorin measurements were carried out in SH-SY5Y cells as previously described (19, 48) .
